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Background:There is an increasing need to integrate phenotypemeasurement data across
studies for both human studies and those involving model organisms. Current practices
allow researchers to access only those data involved in a single experiment or multiple
experiments utilizing the same protocol. Results: Three ontologies were created: Clini-
cal Measurement Ontology, Measurement Method Ontology and Experimental Condition
Ontology. These ontologies provided the framework for integration of rat phenotype data
from multiple studies into a single resource as well as facilitated data integration from mul-
tiple human epidemiological studies into a centralized repository. Conclusion:An ontology
based framework for phenotype measurement data affords the ability to successfully inte-
grate vital phenotype data into critical resources, regardless of underlying technological
structures allowing the user to easily query and retrieve data from multiple studies.
Keywords: ontology, phenotype
BACKGROUND
The quest to link characteristics of an individual or organism to
genetic structures dates to the mid-1800s and the work of Gregor
Mendel (Sorsby, 1965). In the past 20 years, a great deal of progress
has beenmade in identifying,naming, and standardizing the infor-
mation about genetic structures. The International Nucleotide
Sequence Database Collaboration1 was created to develop stan-
dard formats for genomic data to integrate data generated at
multiple laboratories using a variety of technologies resulting in
public databases housed at the National Center for Biotechnology
Information (NCBI; Sayers et al., 2010), the DNA Databank of
Japan (Kaminuma et al., 2010), and the European Bioinformatics
Institute (EBI; Goujon et al., 2010). This integration of data has led
to the development of numerous data mining, presentation, and
analysis tools and provides a platform for comparisons of genetic
and genomic structures across species. Unfortunately, a similar
development in data standards and integration has not occurred
for the characteristics of an individual or organism scientists wish
to link to these structures. The potential value of integrating phe-
notype data from multiple sources (e.g., different laboratories or
studies, varying techniques to measure similar phenotypes, multi-
ple populations, or strains of a particular organism) is enormous.
The power to identify novel genes associated with human disease
and the role a gene plays in disease is greatly increased with clearly
deﬁned phenotype information and the inclusion of the envi-
ronmental and experimental context (Butte and Kohane, 2006).
However, most phenotype data is gathered or generated without
thought to integrating the results with those from other studies
even within the same laboratory or program, creating barriers
to integrating and comparing results reported in publications. In
both animal and human physiological and disease studies, there
1http://www.insdc.org/
has been a long tradition of designing new protocols and adopting
evolving best practices available at the time the study is launched.
As a result, the same basic information gets collected differently
across protocols. This leads to a common belief that each study is
unique and cannot be compared to any other for anything more
than the most general elements. Moreover, the data sets and study
information are structured in such a way that, often, only those
who are intimately familiar with the study understand the full
depth of the data; this includes details such as the measurement
methods used and the experimental conditions imposed. Formost
researchers, ferreting out this information from different studies
requires extensive time and effort, as is generally experienced by
post hoc collaborations among multiple studies. Even when these
details are published, they are often described in widely different
ways without full inclusion of details making comparisons across
studies not only difﬁcult but sometimes impossible.
Variations in experimental conditions, population, age, and
study design all contribute to the difﬁculty in comparing phe-
notype data from multiple sources. For example, the comparison
of blood pressure measured in different laboratories or programs
can be impacted by the way in which blood pressure is mea-
sured (e.g., direct measurement via catheter in artery, telemetry,
blood pressure cuff), the experimental conditions imposed as part
of the study (e.g., low salt/high salt diet, exercise, oxygen lev-
els), surgical manipulations (e.g., removal of a kidney), gender,
and age. One approach to aggregating and integrating phenotype
data would be to develop standard phenotyping protocols to be
followed by all researchers. However, standardizing the methods
used for phenotyping protocols has signiﬁcant drawbacks. Many
would see it as impractical since each researcher is testing fairly
unique hypotheses which cannot be easily investigated by using
a set protocol. Additionally, not all laboratories measure phe-
notypes using the same assays, nor do all investigators agree on
one perfect method to measure each phenotype. Any movement
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toward this type of standardization would take years before results
were evident, keeping existing data resources inaccessible. A more
practical approach is to develop a method using ontologies and
standardized data formats to integrate phenotype measurement
data sets.
A number of groups have focused on standardizing biological
information through standardized vocabularies and ontologies.
Ontologies are hierarchically structured vocabularies of terms and
relationships that are clearly deﬁned and designed to represent and
communicate information about a particular scientiﬁc domain
(Figure 2). The entities and concepts represented by the terms in
the lower nodes are assumed to inherit the properties and qualities
of those of nodes higher up the branch. The National Institutes of
Health, in recognition of the utility of ontologies and the need
for more ontologies to represent biological concepts, provided
funding for the creation of the National Center for Biomedical
Ontology (NCBO)2 in 2006 (Rubin et al., 2006). There are cur-
rently 242 ontologies cataloged at NCBO including several which
focus on phenotypes.
MAMMALIAN PHENOTYPE ONTOLOGY
The Mammalian Phenotype (MP) Ontology was initially created
for annotating gene alleles at the Mouse Genome Informatics
(MGI) database (Smith et al., 2005). For the MP ontology, “phe-
notype refers to the observable morphological, physiological, and
behavioral characteristics of an individual in the context of the
environment” (Smith and Eppig, 2009). BecauseMPwas designed
to be used with mouse knockouts, mutations, and other types
of alleles, there is an underlying assumption of a comparison
to the trait exhibited by a mouse with the genetic background
from which the allele has been constructed or a comparison
to a normal or “wild type” trait. Thus the terms often contain
words such as “abnormal,” “increased,” or “decreased” with the
implication of “relative to” an assumed observation. The actual
measured values for observed traits are not connected to these
annotations. MP follows the open-source Open Biological and
Biomedical Ontology (OBO) ﬁle format and is organized on the
Directed Acyclic Graph (DAG) structure with the highest nodes
related to physiological systems such as cardiovascular, immune
system as well as behavioral, life span, and cellular phenotypes.
Each physiological system node is followed by a basic division
into physiological and morphological phenotype branches. MGI
currently has over 41,000 genotypes annotated with MP terms
for a total of more than 193,000 annotations. MP is consid-
ered a pre-coordinated term ontology since both the entity (i.e.,
anatomical site or physiological process) and the quality of it
(i.e., abnormal, increased, decreased) are included in the term.
MP is also being used for the EuroPhenome project to anno-
tate mutant mouse phenotype data generated using standard
phenotyping platforms (Morgan et al., 2010). The advantages
in terms of annotation are signiﬁcant since curators only have
to search a single ontology and has terms that more closely
mimic those seen in literature and commonly used in laboratory
settings.
2http://bioontology.org/
PHENOTYPE AND TRAIT ONTOLOGY
Another approach to phenotype ontologies has been the Phen-
toype and Trait Ontology (PATO) project3 (Gkoutos et al., 2004).
Unlike MP which is considered a pre-coordinated term phe-
notype ontology, PATO uses the EQ approach (entity+ quality;
Gkoutos et al., 2004; Smith and Eppig, 2009). Thus PATO presents
terms related to qualities and attributes that are then linked
to terms from other ontologies such as anatomy ontologies to
describe phenotypic characteristics. Thus, “big ears” would be
represented by the term “increased size” from PATO and the
word “ear” from an anatomy ontology (Mungall et al., 2010).
One of the advantages of this approach is the re-use of existing
ontologies such as the anatomy ontology. Representing morpho-
logical traits through the use of anatomy ontologies and the
qualities described in PATO is relatively straight forward. This
is one reason that resources housing data for some organisms
such as drosophila and zebraﬁsh have found this approach use-
ful (Mungall et al., 2010); the majority of their reported traits
and phenotypes are morphological in nature. However, the repre-
sentation of physiological traits and speciﬁc clinical measurement
types is more problematic (Smith and Eppig, 2009). First, there
is not necessarily a single ontology that adequately represents
the physiological trait corresponding with the quality expressed
by PATO; and second, a single EQ term may not adequately
express the phenotype observed. For example while the mor-
phological trait of “big ears” is relatively easy to represent by
EQ, an MP term of “abnormal cochlear outer hair cell elec-
tromotility” provides a greater challenge. The disadvantages of
the PATO approach for annotation are also signiﬁcant. Curators
would have to browse multiple ontologies to create a term on the
ﬂy and this approach creates terms and phrases that sometimes
are stilted or not commonly used in the literature or laboratory
settings.
HUMAN PHENOTYPE ONTOLOGY
TheHuman Phenotype Ontology (HPO) was developed in part to
address the shortcomings of information presented in the Online
Mendelian Inheritance in Man (OMIM) database4 (Amberger
et al., 2009). OMIM has traditionally been the most commonly
used resource for information on genetic diseases. Unfortunately,
the information housed there is in free text format,making it difﬁ-
cult to mine computationally because of the non-standard way in
which traits and abnormalities are described. For instance,OMIM
uses the synonymous descriptions“generalized amyotrophy,”“gen-
eralized muscular atrophy,” and “muscular atrophy, generalized”
so even simple searches may not return the results a user desires.
While a human reader going through the free text of multiple
entries will recognize similar meanings, computers will not. The
initial version of HPOwas created using the information atOMIM
in an effort to merge synonyms and create links and relation-
ships among the terms and concepts. This initial structure has
been expanded and reﬁned through manual curation of infor-
mation from a variety of sources and consistent development of
deﬁnitions and relationships (Robinson and Mundlos, 2010). As
3http://www.bioontology.org/wiki/index.php/PATO:Main_Page
4http://www.ncbi.nlm.nih.gov/omim
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with MP, the emphasis has been on phenotypes which diverge
from the normal or expected and disease states and terms are
pre-constructed as with the MP.
Ontologies such as MP, PATO, and HPO were originally
designed for use in simple annotations to a single data (e.g., gene
product or allele) or an individual and the term was expected to
appear alone in the annotation with the minimal accompanying
information of an evidence code indicating level of experimen-
tal evidence to support the annotation and the reference from
which the annotation was made. The existing phenotype ontolo-
gies were not developed to be attached to actual measurement
values but to indicate a state or characteristic observed relative to
that which has been determined to be “normal” or “wild type,” or
relative to that exhibited by an individual with a known genotype.
Information on experimental conditions and measurement assays
used are vital parts of the phenotype record and the use of mul-
tiple ontologies to represent these has been advocated as a way to
accomplish this (Shimoyama et al., 2005; Hancock et al., 2007).
Clearly, developing separate ontologies for the elements of phe-
notype measurement, method of measurement, and conditions
under which the measurement was made along with provisions
for additional information on actual values, duration of condi-
tions, and so on, will allow these aspects of the phenotype record
to be linked. Database structures which allow re-use of informa-
tion and multiple associations will facilitate data integration, data
mining, and data presentation.
In this paper, we present three ontologies created to standard-
ize phenotype measurement records for use in human studies and
those using laboratory animals: Clinical Measurement Ontology
(CMO), Measurement Method Ontology (MMO), Experimental
Condition Ontology.
MATERIALS AND METHODS
The standard elements of phenotype measurement records were
identiﬁed as: (1) what was measured, (2) how it was measured,
and (3) under what conditions it was measured. Ontologies were
developed to standardize each of these elements (Figure 1) and
include (1) CMO, (2) MMO, and (3) Experimental Conditions
Ontology (XCO).
The ontologies are available through theNCBOBioportal5, and
at the Rat Genome Database in ftp ﬁles6. The ontologies undergo
revisions and updates for both consistencies in format and to
extend the breadth and depth of coverage as new measurement
records are added. The ontologies were developed using the OBO
format and the OBO Edit tool (Day-Richter et al., 2007) available
at the NCBO, through its Foundry project (Smith et al., 2007).
While developed in OBO, developments in OBO to Web Ontol-
ogy Language (OWL) mapping tools should facilitate conversion
to this other highly used ontology format. The major ontology
5http://bioportal.bioontology.org/
6http://rgd.mcw.edu/pub/ontology
FIGURE 1 |Three ontologies were developed to standardize the three elements of a measurement record: what was measured, how it was measured
and under what conditions it was measured.
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development tools, OBO Edit for OBO and Protege for OWL now
offer widgets that facilitate conversion from one ﬁle format to the
other (see text footnote 2). The OBO Relation Ontology (RO) was
used to create consistency in relationship representations (Smith
et al., 2007). These ontologies follow the form of DAGs in which
there is a set of nodes with edges forming the linkage between
nodes (Robinson and Mundlos, 2010). The nodes are the terms in
the ontologywith the edges representing the relationships between
nodes and the overall visualization of such ontologies resembles
branches. In DAGs, the edges or relationships are one way,moving
from one node to another, and they do not cycle back. The general
relationship pattern in many of these ontologies is a movement
from the more general (higher nodes) to the more speciﬁc (lower
nodes). The entities and concepts represented by the terms in the
lower nodes are assumed to inherit the properties and qualities of
those of nodes higher up the branch.
The development of these ontologies has included cross ref-
erences with other ontologies when an exact match of the entity
exists. For example, relationships were created with ChEBI in the
Experimental ConditionOntology and to the Electrocardiography
Ontology (ECG) exist in the CMO. These relationships were cre-
atedmanually and are not used to create cross products. Cross ref-
erencing to other ontologies, such as the Cell Ontology, Evidence
Code Ontology, and other ontologies used for the reporting of
phenotypes, will continue with both manual and semi-automated
methods as the ontologies are extended.
CLINICAL MEASUREMENT ONTOLOGY
The CMOprovides the standardized vocabulary necessary to indi-
cate the type of measurement made to assess a trait. For the
purposes of this project and these ontologies, trait and clinical
measurement are deﬁned as follows:
Trait
A physiological or morphological state or property found in all
members of a species. Traits can be described or assessed quan-
titatively (numerically) or qualitatively based on the results of an
appropriate form of measurement. The assessment of the trait is
not equivalent to the trait itself. Traits exist even when they are not
assessed or measured. Often multiple forms of measurement are
used to assess a single property or state.
Measurement
The act or result of the act of assessing a morphological or phys-
iological state or property in a single individual or group of
individuals and assigning a quantitative or qualitative value. A
measurement does not exist until it is performed or taken. Often
a single measurement can be used to assess multiple properties or
states, sometimes in conjunction with other measurements.
For example, all humans have intelligence or mental capacity,
but not all human individuals have an IQ because it has not yet
been measured. Similarly, all humans have a body mass but they
do not all have a bodyweight because it has not yet beenmeasured.
Each term in theCMOdescribes a distinct type ofmeasurement
used to assess one or more traits. The terms are arranged in a hier-
archical structure of classes so that lower classes are subclasses of
higher classes in the branch (Figure 2).
This represents an “is_a” type relationship so that a lower term
“is_a” subclass of a higher term. Thus, blood cell measurement
“is_a” blood measurement and complete blood cell count “is_a”
blood cell measurement. The measurements in the ontology are
primarily organized on the highest level according to the body sys-
tem in which the measurement is made. Trait areas were targeted
for ontology development based on the availability and extent of
data in large scale rat phenotyping projects,published rat literature
with phenotype measurements and targeted human epidemiolog-
ical studies. Ontology development began with the identiﬁcation
of clinical measurements used to assess targeted traits, with terms
and deﬁnitions being created and relationships among terms being
set (Figure 3).
Existing ontologies at NCBO were reviewed for associated
terms and deﬁnitions. Because the clinical measurements in the
targeted sources may be limited, additional literature including
medical and physiological textbooks, laboratory manuals, and
published research literature were reviewed to ensure complete-
ness in the ontology. For example, to assess kidney mass the
data source may only use right kidney weight. Further review
of a variety of sources reveals that other typical measurements
would include left kidney weight, weight of both kidneys, kid-
ney weight expressed as a percentage of body weight which are
also often used to assess the trait of kidney mass so these were
also added to the ontology. For every clinical measurement term
created, associated measurement method terms and experimen-
tal condition terms were created based on data in the originating
sources as well as the review of additional literature and exist-
ing ontologies. There are currently 523 terms in the CMO for
measurement types ranging from morphological to physiological
for blood, cardiovascular, respiratory, renal, and other systems as
well as for growth, reproduction, consumption, tumors, and tissue
composition.
MEASUREMENT METHOD ONTOLOGY
A critical element in the description of a phenotype is the mea-
surement method used. Several types of methods are commonly
used to measure such things as blood pressure resulting in dif-
fering clinical measurement values so the inclusion of method as
part of the measurement reading is necessary for the integration
of data from multiple studies. The MMO is designed to provide
this information. As described above, this ontology was developed
in parallel with the CMO as trait areas are targeted. The MMO
is organized by the underlying principle or mechanism of the
method (Figure 4) with two major branches, “ex vivo method”
and “in vivo method.” Methods were identiﬁed from protocol
descriptions and data labels from the targeted data sources.Aswith
the CMO, for completeness in the ontology, additional sources of
method information such as vendors’ catalogs, laboratory manu-
als, and published literature were reviewed for associatedmethods.
Thus, if one of the protocols for one of the originating data sources
indicated that a balloon tipped catheter was used tomeasure blood
pressure, a quick review of a variety of publications revealed that
the basic category is vascular indwelling catheter with a variety of
types including ﬂuid ﬁlled catheter, intravascular electromagnetic
ﬂow sensor, and transducer tipped catheter. There are currently
195 terms in the MMO.
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FIGURE 2 |The Clinical Measurement Ontology is presented in a hierarchical structure with classes lower down a branch being subclasses of those
above with an “is_a” relationship.
FIGURE 3 | Each CMO term was created as phenotype domains addressed with appropriate definitions for each term.
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FIGURE 4 |The Measurement Method Ontology structure is based on two major branches, “ex vivo” and “in vivo” and the underlying mechanism or
technique used in the method.
EXPERIMENTAL CONDITION ONTOLOGY
While many phenotype measurements are made under baseline
conditions, changes to diet, atmosphere, activity level, and other
conditions are common aspects of phenotype experiments. Often
this information is added as part of the phenotype label in the indi-
vidual laboratory’s database or only included as part of a lengthy
text protocol. Creation of standardized terminology and format
for presenting this information with phenotype measurements
is crucial to the integration of phenotype data from multiple
datasets. An XCO was created to provide standardization and
structure for this important information (Figure 5).
In addition, to the “is_a” relationship, in certain areas a
“part_of” relationship is utilized so that parts of a whole can be
described as in“air oxygen content”is“part_of”“atmosphere com-
position.” The ontology was designed so that conditions related
to existing ontologies such as those involving chemicals or drugs
represented in ChEBI (Degtyarenko et al., 2009), follow the struc-
ture and terminology of these ontologies and provide appropriate
linkages through identiﬁers (Figure 5). Initial emphasis was on
the conditions used in the targeted data sets and expanded to
those conditions most commonly used in experiments involving
the targeted trait domains. Structural provisions in the database
structures of projects using the ontology provide ordinality infor-
mation to indicatewhethermultiple conditionswere simultaneous
or sequential. Use of this ontology in annotating phenotype data
allows users to retrievemultiple, disparate phenotype information
in which similar experimental conditions were imposed. There are
currently 110 terms in the XCO.
DATA INTEGRATION
The three ontologies have been used to integrate multiple data sets
for two major projects, one involving human data and the other
involving rat data. The Cardiovascular Ontologies andVocabular-
ies in Epidemiological Research project was designed to integrate
demographic and phenotype measurement data from three fam-
ily blood pressure studies, Hypertension Genetic Epidemiology
Network (HyperGEN; Williams et al., 2000); Genetic Epidemi-
ology Network of Salt Sensitivity (GenSalt; Gu et al., 2007);
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FIGURE 5 |The Experiment Condition Ontology is structured by type of condition with both “is_a” and “part_of” relationships with links to identifiers
found in other ontologies.
and HEalth, RIsk factors exercise Training And GEnetics (HER-
ITAGE; Bouchard et al., 1995). While all three studies focused
on cardiovascular disease and associated risk factors, they were
disparate in the types of interventions used, variety of measure-
ments taken and the methods used to make the measurements.
Measurements related to blood pressure, blood chemistry and
lipid levels, body weight and body fat were included as well as
interventions ranging from sodium controlled diets to exercise.
Invasive, non-invasive and imaging techniques were also used.
The HyperGEN study was designed to characterize the genes
inﬂuencing hypertension by recruiting hypertensive sibships (i.e.,
each participant with two or more hypertensive sibs) from across
multiple ﬁeld centers and ethnic groups. The GenSalt study is
an intervention study of the genetic and environmental fac-
tors related to dietary sodium and potassium effects on blood
pressure in rural Chinese families. The HERITAGE study is an
intervention study designed to assess genetic and environmen-
tal factors underlying the effects of endurance exercise training
on several cardiorespiratory and cardiovascular disease risk fac-
tors. The CMO, MMO, and Experimental Condition Ontology
were used to map data elements from each of the studies to
a common format for integration into a single resource7. To
date, 16 phenotype classes with records for 8,778 subjects have
been integrated for the three studies and made available at the
7http://cover.wustl.edu/Cover/
website. Additionally, all variables across the studies are being
mapped and modeled with their associated ontology terms to
facilitate querying and access to raw data ﬁelds of interest; to
date 11 classes have been created representing over 100 phenotype
measurements.
The rat PhenoMiner project8 (Figure 6) also has used the three
ontologies to deﬁne data formats and standards for integrating rat
phenotype measurement data from a variety of sources includ-
ing two large scale phenotyping projects and published literature.
PhysGenProgram forGenomicApplications9 (Kwitek et al., 2006),
one of the large scale phenotyping projects was designed to con-
duct high throughput phenotype screening for a targeted set of
inbred strains, as well as consomic andmutant strains. The screens
involved hundreds of different types of phenotype measurements
for heart, lung, renal, vascular, and blood function under base-
line conditions as well as varying diet, atmosphere, and activity
conditions. Data was organized, stored, and presented by proto-
col so even though some similar measurements such as weight or
blood pressure were measured in multiple protocols, the data was
not integrated across protocols. The National BioResource Project
for the Rat in Japan (Serikawa et al., 2009) was the second large
scale rat phenotyping project. Phenotype screens for body weight,
activity, behavior, blood pressure, blood chemistry, urine analysis,
8http://rgd.mcw.edu/phenotypes/
9http://pga.mcw.edu/
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FIGURE 6 |The PhenoMiner website.
and organ weights have been conducted under baseline conditions
for inbred and mutant strains.
Because the rat is an ideal model organism for pharmacology,
biochemistry, and physiology research, the published literature
is a rich resource of data on phenotype measurements for par-
ticular strains. Papers reporting cardiovascular, respiratory, renal,
morphological, and blood chemistry measurement data as well as
those with measurements related to cancer were targeted for the
initial phase of the PhenoMiner resource. Over 13,000 measure-
ment records from these three sources have been mapped to the
three ontologies and integrated into PhenoMiner (Figure 7).
DISCUSSION AND CONCLUSION
The three ontologies created have proven to be excellent tools for
standardizing phenotype measurement data for projects involv-
ing a wide variety of data types and data sources. Targeting the
three basic elements of: (1) what was measured; (2) how it was
measured; and (3) under what conditions it was measured, facil-
itated standardization while allowing for ﬂexibility in providing
associated information such as units of measurement or duration
of condition to be formatted in ways particular to the integrat-
ing resource. These ontologies allowed phenotype measurement
data from disparate studies to be integrated without compro-
mising study-speciﬁc aspects related to methodology. Multiple
datasets of human epidemiological data and rat phenotype data
were successfully integrated into resources designed to meet the
needs of diverse research communities even though the underly-
ing technological framework for the databases and associated tools
differed. While integrating varied phenotype datasets was the pri-
mary motivation for the development of these ontologies, they
can be deployed in a variety of other projects as well. Because of
their availability at NCBO, they can be utilized with the NCBO
Annotator, aWeb service that annotates journal abstracts10 which
facilitates curation efforts and queries for appropriate literature
for speciﬁc projects. Because of their focus on experimental data,
the use of these ontologies in text mining tools would also help
investigators identify and prioritize literature.
Creating structures to integrate phenotype measurement data
from multiple sources is an important task as investigators draw
on the strength of the genomic and sequence variation resources
to identify underlying genotype factors related to phenotypes
and diseases. In order to make these connections, researchers
need to easily access and analyze phenotype measurement data
related to individuals and various model strains, and informa-
tion on experimental conditions and methodologies that may
affect the measurement values. Employing multiple ontologies
to standardize data formats facilitates the integration of these
vital datasets and provides the structure on which innovative
data mining, analysis, and presentation tools can be built. These
types of resources can provide researchers with a more accurate
10http://bioportal.bioontology.org/annotator#
Frontiers in Genetics | Bioinformatics and Computational Biology May 2012 | Volume 3 | Article 87 | 8
Shimoyama et al. Ontologies to deﬁne phenotype measurements
FIGURE 7 | Example of phenotype measurement data from multiple studies mapped to the three ontologies for clinical measurement, measurement
method, and experimental condition.
picture of phenotype variations among populations and as well as
the impact of measurement methods may have on measurement
results. The inﬂuence of experimental and environmental condi-
tions on phenotypes and disease will also be easier to elucidate
when researchers have access to large numbers of measurements
from a wide variety of studies. This is an important step in help-
ing investigators link genotypes to phenotypes. Finally, the use
of multiple ontologies to standardize data elements into single
quantiﬁable records can be used in many paradigms to integrate
datasets. Convergence among phenotyping efforts can be fostered
using this methodology through the use of existing ontologies,
such as MP, PATO, and HPO, in conjunction with ontologies that
further reﬁne the phenotype data. Engaging other communities
will provide the platform for data mining across species or across
phenotyping programs using a variety of phenotyping protocols.
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